Deze vertaling wordt voorbereid. Voorlopig tonen we de oorspronkelijke Engelse versie.
Bedrijven · 2-2-19981 min lezen
Developing Regulations for In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring; Public Meeting
Lokale automatische vertaling · Oorspronkelijke brontaal
Samenvatting
The Food and Drug Administration (FDA) is announcing a public meeting entitled ``Developing Regulations for In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring.'' The purpose of the public meeting is to provide a forum for FDA to gather information for the development of new regulations for the review of radiopharmaceutical applications as required by the Food and Drug Administration Modernization Act of 1997 (the FDAMA).
Oorspronkelijke brontaal: Federal Register — Food and Drug AdministrationOrigineel bericht openen →